about
Microtubule-binding agents: a dynamic field of cancer therapeutics.Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Interactions of antimitotic peptides and depsipeptides with tubulin.Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasStrategies to address drug interaction potential for antibody-drug conjugates in clinical development.Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulationPharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
P2860
Q27690249-092CFD7B-9106-474F-98A0-4C57D90F0A02Q33834080-7A7349E0-EA4E-44B5-94B2-C2215B7299DAQ34972878-F13B2946-BACB-491E-BF30-A72BC6756424Q36674450-73641B89-163E-4E5F-8213-0FF687BE4D25Q38103883-0D990375-9AE0-4CF0-97DF-D0A535CFA4CAQ41907216-3A581DE1-66BA-4157-9987-A2F4E418D580Q47661007-57B3C0B6-3EE1-4B7F-BA08-573BC60B0FD9Q48773255-4A2E6B76-DB3C-41FE-815E-A8D6A7F2720A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Role of P-glycoprotein in dolastatin 10 resistance.
@en
type
label
Role of P-glycoprotein in dolastatin 10 resistance.
@en
prefLabel
Role of P-glycoprotein in dolastatin 10 resistance.
@en
P2093
P1476
Role of P-glycoprotein in dolastatin 10 resistance.
@en
P2093
P304
P356
10.1016/0006-2952(94)90292-5
P407
P577
1994-08-01T00:00:00Z